A new treatment for gonorrhea shows promise, which is welcome news with global rates of the sexually transmitted infection on the rise and antibiotic resistance becoming more prevalent. The oral ...
Add Yahoo as a preferred source to see more of our stories on Google. Specifically, the spokesperson mentioned a frequently prescribed antibiotic known as azithromycin, and said that, overall, ...
As if hantavirus and Ebola outbreaks weren’t enough, sexually transmitted infections are surging across Europe. Gonorrhea and ...
A new antibiotic has proven as effective as the last remaining recommended treatment for gonorrhea, helping to assuage mounting fears among public health experts about the emergence of drug-resistant ...
An important Phase 3 trial has shown that a new drug that targets gonorrhea works as well as the last existing antibiotic to treat the sexually transmitted infection, results that could lead to ...
The incidence of gonorrhea continues to increase in Spain and across Europe, highlighting an urgent need for new prevention strategies, including vaccines, despite recent clinical trial setbacks. In ...
Europe is dealing with a full-blown sexual health crisis as cases of gonorrhea and syphilis skyrocket to unprecedented levels ...
The Nunavut government says it's seeing an increase of cases of gonorrhea in its communities, especially in the Kitikmeot region. In a public health advisory news release Tuesday afternoon, the ...
Add Yahoo as a preferred source to see more of our stories on Google. Gonorrhea is on the rise in the U.S. (Photo: Getty Images) (Getty / Nadeen Nakib for Yahoo Life) Cases of gonorrhea are ...
The FDA approved gepotidacin (Blujepa), an oral option for the treatment of uncomplicated urogenital gonorrhea among patients ages 12 years and older, GSK announced on Thursday. "The ability of N.
Gonorrhea is a common sexually transmitted disease (STD) that causes infection in more than 1.5 million people every year in the United States. The infection is caused by Neisseria gonorrhoeae, a type ...
WALTHAM, Mass. & GENEVA--(BUSINESS WIRE)--Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (NASDAQ: INVA), in collaboration with the Global Antibiotic Research & Development ...